Award
NIH Reporter #1R43DK141319-01
Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
Recipient
Not Specified
Award Amount
$306,872.00
Ceiling
$306,872.00
Awarded
May 22, 2025
Identifier
1R43DK141319-01
Award to develop NeuWave, a digital therapeutic platform using electromagnetic fields to improve metabolism and treat type 2 diabetes, including animal studies to support FDA approval.
Description
This project aims to develop a digital therapeutic platform called NeuWave, which utilizes magnetic and electric fields during sleep to rewire carbohydrate and lipid metabolism, thereby increasing glucose utilization and insulin sensitivity in type 2 diabetes (T2D). The project involves animal studies in lean and obese-diabetic rats to assess the feasibility, safety, and biomarkers of the therapy, with the goal of supporting FDA approval and clinical trials.